Business Context and Reporting Period
This Form 8-K filing by ICU Medical, Inc. (ICUI) reports on events occurring at the Company's 2025 Annual Meeting of Stockholders held on May 13, 2025. The filing details the results of shareholder votes and the approval of amendments to the Company's equity incentive plan.
Key Financial Metrics
This filing is a current report regarding corporate governance and equity plan amendments. It does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. Investors should refer to the Company's most recent Form 10-K or 10-Q for financial statements.
Material Changes and Corporate Actions
- Stock Incentive Plan Amendment: Shareholders approved the third amendment to the 2011 Stock Incentive Plan. This amendment increases the number of shares available for issuance by 2,150,000, bringing the aggregate total to 8,515,510 shares. The same increase applies to shares available for Incentive Stock Options (ISOs).
- Director Elections: All seven director nominees were elected by shareholders. Broker non-votes totaled 2,145,693 for each nominee.
- Executive Compensation: Shareholders approved, on an advisory basis, the compensation of named executive officers.
- Voting Policy Change: Shareholders approved, on an advisory basis, a stockholder proposal to adopt simple majority voting.
- Auditor Ratification: The appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future financial guidance, market outlook, or specific risk factors. The document focuses strictly on the procedural outcomes of the Annual Meeting. The Plan Amendment text is incorporated by reference from the Definitive Proxy Statement filed on April 3, 2025.
Key Facts for Investor Verification
- Verify the impact of the 2,150,000 share increase on potential future dilution.
- Review the full text of the Third Amendment to the 2011 Stock Incentive Plan (Exhibit 10.1) for specific terms and conditions.
- Confirm the simple majority voting adoption status, as this was an advisory stockholder proposal.
- Note that Deloitte & Touche LLP remains the independent auditor for the 2025 fiscal year.